Volume 36, Issue 6 1 pp. 1268-1273
Article

Evaluation of Postoperative Radioactive Iodine Scans in Patients who Underwent Prophylactic Central Lymph Node Dissection

Amanda M. Laird

Corresponding Author

Amanda M. Laird

Division of Endocrine Surgery, Section of General Surgery, Department of Surgery, University of Michigan, 2920 Taubman Center, 1500 E. Medical Center Dr, SPC 5331, 48109-5331 Ann Arbor, MI, USA

[email protected]Search for more papers by this author
Paul G. Gauger

Paul G. Gauger

Division of Endocrine Surgery, Section of General Surgery, Department of Surgery, University of Michigan, 2920 Taubman Center, 1500 E. Medical Center Dr, SPC 5331, 48109-5331 Ann Arbor, MI, USA

Search for more papers by this author
Barbra S. Miller

Barbra S. Miller

Division of Endocrine Surgery, Section of General Surgery, Department of Surgery, University of Michigan, 2920 Taubman Center, 1500 E. Medical Center Dr, SPC 5331, 48109-5331 Ann Arbor, MI, USA

Search for more papers by this author
Gerard M. Doherty

Gerard M. Doherty

Division of Endocrine Surgery, Section of General Surgery, Department of Surgery, University of Michigan, 2920 Taubman Center, 1500 E. Medical Center Dr, SPC 5331, 48109-5331 Ann Arbor, MI, USA

Search for more papers by this author
First published: 20 January 2012
Citations: 36

Abstract

Background

Prophylactic central lymph node dissection (CLND) accompanying total thyroidectomy for papillary thyroid cancer (PTC) remains controversial. Our hypothesis is that CLND may help select patients who benefit from postoperative radioactive iodine (RAI).

Methods

A total of 119 patients who were clinically node-negative underwent total thyroidectomy/bilateral CLND for papillary thyroid cancer (PTC) > 1 cm during 2002–2010. Pathology results, RAI results, and outcomes were compared between node-positive (NP) and node-negative (NN) patients.

Results

NP and NN patients were similar in age, gender, tumor size, and MACIS score. Median number of nodes excised was six. The rate of permanent hypocalcemia was 1.7% without permanent recurrent laryngeal nerve injuries. Thirteen of 52 (25%) NN patients and 24 of 67 (36%) NP patients had suspicious nodes by intraoperative inspection. The node assessment negative predictive value was 75%; positive predictive value was 36%. Fifty-six percent (67/118) were NP; 100 patients were treated with RAI. Fourteen of 62 NP patients had abnormal postoperative RAI scans aside from the thyroid remnant versus 4 of 38 NN patients (23 vs. 11%, p = 0.18). Median 1-year stimulated thyroglobulin (Tg) level was 0.0 for both (range 0.0–1.2, NN; 0.0–22.7, NP; p = 0.1). NP patients received higher doses of RAI (150 vs. 30 mCi, p < 0.001). Rate of recurrent or persistent disease was 3.4%.

Conclusions

Few node-negative patients have abnormal RAI scans outside of the thyroid bed. Node-positive patients had greater variability in stimulated 1-year Tg levels after higher doses of RAI. CLND may identify the patients most likely to have persistently elevated stimulated Tg after initial therapy for PTC.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.